Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
ROG Xbox Ally X review – like nothing handheld gaming has seen before, for better or worse
16/10/2025
UK students : have you been targeted by scammers ?
16/10/2025
‘Prince Andrew believed having sex with me was his birthright’ : Virginia Giuffre on her abuse at the hands of Epstein, Maxwell and the king’s brother
15/10/2025
Season of the witch : 40 stylish, mystical treats, from crystal rings to pumpkin prints
15/10/2025
Jess Cartner-Morley on fashion : the number-one rule for coats this winter – make it long
15/10/2025
The South West Coast Path’s ‘forgotten section’ : the quiet pleasures of south-east Cornwall
15/10/2025